Healthcare Triangle
HCTI
1 hedge funds and large institutions have $282K invested in Healthcare Triangle in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
28% less capital invested
Capital invested by funds: $392K → $282K (-$110K)
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$42K |
| 2 |
Renaissance Technologies
New York
|
-$26K |
| 3 |
VF
Virtu Financial
New York
|
-$21K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$12K |
HCTI Hedge Fund Activity: Q1 2022 in Review
1 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Healthcare Triangle (HCTI) for Q1 2022, worth a combined $282K — down 28% from $392K a quarter earlier.
Fund positioning in HCTI was balanced in Q1 2022: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
The largest seller was Two Sigma Securities, cutting an estimated $42K.
- 1 institutional investor held Healthcare Triangle (HCTI) as of Q1 2022, unchanged from Q4 2021.
- Funds reported $282K of Healthcare Triangle stock for Q1 2022, down 28% quarter-over-quarter.
- 0 funds opened new Healthcare Triangle positions in Q1 2022 and 0 closed out.
- The largest Healthcare Triangle seller in Q1 2022 was Two Sigma Securities, an estimated $42K sold.
Based on aggregated 13F filings for Q1 2022.